Stay updated on FT538 with Daratumumab in AML Clinical Trial

Sign up to get notified when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FT538 with Daratumumab in AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    New versions in the record history show updates to Study Status and Recruitment Status. The changes reflect the trial’s evolving state and its enrollment status.
    Difference
    0.2%
    Check dated 2025-11-03T20:49:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.
    Difference
    12%
    Check dated 2025-10-06T05:15:56.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.3%
    Check dated 2025-09-29T02:59:43.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Updated revision to v3.0.2 and removed the Back to Top link; no changes to core content, pricing, stock, or time slots.
    Difference
    0.7%
    Check dated 2025-09-14T18:52:28.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.7%
    Check dated 2025-09-07T13:36:29.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    16%
    Check dated 2025-08-31T11:31:39.000Z thumbnail image

Stay in the know with updates to FT538 with Daratumumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.